29.10.2014 Views

the current newsletter as a .PDF - Joslin Diabetes Center

the current newsletter as a .PDF - Joslin Diabetes Center

the current newsletter as a .PDF - Joslin Diabetes Center

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PAGE 4<br />

NEWSLETTER OF THE PEDIATRIC, ADOLESCENT, & YOUNG ADULT SECTION<br />

Research Opportunities at <strong>Joslin</strong><br />

T1D Exchange<br />

Description: The Type 1 <strong>Diabetes</strong> (T1D) Exchange is<br />

a nationwide registry collecting information about children<br />

and adults with type 1 diabetes. The purpose of<br />

<strong>the</strong> registry is to ga<strong>the</strong>r information about people with<br />

type 1 diabetes to help better understand <strong>the</strong> natural<br />

course of type 1 diabetes and <strong>the</strong> effectiveness of <strong>current</strong><br />

treatments. Participation in <strong>the</strong> registry involves<br />

completion of a questionnaire about medical and family<br />

history including diabetes diagnosis and treatment<br />

and laboratory test results. Annual updates of information<br />

are also part of <strong>the</strong> registry.<br />

Recruiting: At <strong>the</strong> <strong>Joslin</strong>, individuals being followed in<br />

<strong>the</strong> Pediatric, Adolescent and Young Adult Section<br />

may be eligible to participate in this registry.<br />

Contact: Camille Ratliff at (617) 309-4477 or<br />

camille.ratliff@joslin.harvard.edu<br />

RESEARCH UPDATE<br />

Several members of <strong>the</strong> Pediatrics staff attended<br />

<strong>the</strong> 2011 ADA Scientific Sessions in<br />

San Diego, CA, where <strong>the</strong>y presented results<br />

of research accomplished here at <strong>Joslin</strong>. The<br />

well-attended oral and poster presentations described<br />

<strong>the</strong> range of family and social supports that promote<br />

better blood glucose control. These include having<br />

regular contact with a c<strong>as</strong>e manager who educates and<br />

supports <strong>the</strong> young person with diabetes (M. Katz);<br />

having a “Medical Home”, i.e. care that is accessible,<br />

family-centered, continuous, comp<strong>as</strong>sionate, and culturally<br />

effective (M. Katz); and parent goal-setting for<br />

A1c and blood glucose levels (M. Boot et al). The presentations<br />

also addressed <strong>the</strong> impact of diabetes on<br />

families with a survey to me<strong>as</strong>ure <strong>the</strong> burden of diabetes<br />

care (J.Markowitz); and looked at <strong>the</strong> impact of<br />

starting an insulin pump on disordered eating patterns<br />

(J. Markowitz). Ano<strong>the</strong>r presentation reviewed changing<br />

patterns of prescribing medications to treat type 2<br />

diabetes (S. Mehta). One of <strong>the</strong> many interesting sessions<br />

at <strong>the</strong> four-day meeting included a progress report<br />

on <strong>the</strong> Artificial Pancre<strong>as</strong>, where closed-loop systems<br />

using insulin pumps and glucose sensors respond<br />

to high or low blood glucose levels by incre<strong>as</strong>ing or<br />

decre<strong>as</strong>ing insulin delivery respectively. There are<br />

many ongoing studies around <strong>the</strong> globe designing and<br />

evaluating versions of an “artificial pancre<strong>as</strong>.” There<br />

w<strong>as</strong> also a major session on transitions in care from<br />

pediatric to adult diabetes specialists, organized and<br />

chaired by <strong>Joslin</strong>’s Dr. Lori Laffel.<br />

-Alyne Ricker, MD<br />

CGM Improve <strong>Diabetes</strong> Study<br />

Description: The purpose of this<br />

study is to find out how to make it<br />

e<strong>as</strong>ier for children and teens with<br />

type 1 diabetes to use continuous<br />

glucose monitors (CGM) over a long<br />

period of time. The study involves 12<br />

visits over a 24-month period with additional phone contacts<br />

between visits. The extra three visits occur during <strong>the</strong> first<br />

six months of <strong>the</strong> study: <strong>the</strong> rest of <strong>the</strong> visits will occur at<br />

routine clinic visits. Families randomized to <strong>the</strong> intervention<br />

group will receive a family b<strong>as</strong>ed behavioral intervention providing<br />

support and education regarding use of <strong>the</strong> CGM.<br />

Families in <strong>the</strong> usual care group will receive this information<br />

at <strong>the</strong> end of <strong>the</strong> study. Youth in both groups will wear a<br />

CGM device throughout <strong>the</strong> study. Families will be <strong>as</strong>ked to<br />

complete surveys at various intervals over <strong>the</strong> course of <strong>the</strong><br />

study and labwork will be collected for <strong>the</strong> youth in <strong>the</strong> study.<br />

Recruiting: Children and teens, ages 8-17 years, who have<br />

had type 1 diabetes for at le<strong>as</strong>t 1 year and who are receiving<br />

care at <strong>Joslin</strong> and <strong>the</strong>ir parents or legal guardians<br />

Contact: Emily Fisher at 617-309-4644 or<br />

emily.fisher@joslin.harvard.edu<br />

The Tolerance Study<br />

Can Glucose Monitoring<br />

Improve<br />

CGMi Study<br />

Description: This study is trying to help us better understand<br />

what causes type 1 diabetes to help find new ways to prevent<br />

or reverse <strong>the</strong> dise<strong>as</strong>e. The study is being done with<br />

researchers at Harvard Medical School and is funded by <strong>the</strong><br />

Juvenile <strong>Diabetes</strong> Research Foundation. The study visit<br />

includes <strong>the</strong> completion of questionnaires and a blood draw.<br />

Recruiting: Individuals, ages 18 years and older, both with<br />

and without type 1 diabetes<br />

Contact: Roxanne Phillips at 617-309-2481 or<br />

roxanne.phillips@joslin.harvard.edu<br />

Type 1 <strong>Diabetes</strong> Risk Assessment<br />

The Natural History Study — TrialNet<br />

Description: This study aims to identify youth and adults at<br />

risk for type 1 diabetes by testing for diabetes-related antibodies<br />

in relatives of people with type 1 diabetes. It involves<br />

a single blood test. People who test positive will be eligible<br />

for fur<strong>the</strong>r testing and may be eligible to participate in prevention<br />

trials.<br />

Recruiting: Parents, children, & siblings, ages 1-45, and<br />

cousins, grandchildren, nieces, & nephews, ages 1-20, of<br />

people with type 1 diabetes<br />

Contact: Hui Zhang at 617-309-4739 or<br />

hui.zhang@joslin.harvard.edu

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!